Being part of IPVC 2023 Conference program is a great way to push forward your career.
Get recognition for your work, constructive feedback, and new ideas. Share your findings with the papillomavirus society and make a name for yourself in the field.
Abstract Submission Extended Deadline: Tuesday, October 11, 2022.
Abstract submission is free of charge and does not require registration to the Conference or any other binding commitments. Only after being accepted, you will have to register, to be included in the program.
Don’t miss your chance to:
Expand your professional network
Presenting your abstract at IPVC 2023 will allow people to know that you are doing research in HPV and will allow you to connect to future collaborators. Discuss your findings with experts from around the world and meet with colleagues who are interested in your topic.
Gain exposure for your work
Showcase your work in front of like-minded people and get ready to answer questions! Your research will gain wide exposure, you will get valuable feedback and ideas, and your name will be recognised in the program.
Improve your skills
Develop your presentation and communication skills, an essential competence for advancing your career. The more you present your work, the better you become at explaining why your results are important and how they can impact science.
Find your place in the program
Submission allows you to be creative in sharing your presentation in any of the formats available for the Conference. You can also choose among various abstract topics.
Contribute to the future
Sharing your research contributes to our goal of HPV elimination. The research in the field of papillomaviruses can impact the treatment, management, and diagnosis of many conditions. Make a difference!
Win Grants and Awards
Submit an abstract for a chance to win a number of grants and awards available. Abstract submitters will be eligible for these awards if at the time of the abstract submission process they indicate they would like to apply for a registration grant.